Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68180-838

9 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68180-838). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (75083930 2ca4 48c9 A233 24783a0e50d4 01)

Image (75083930 2ca4 48c9 A233 24783a0e50d4 01)
A forest plot showing effect estimates (Odds Ratios/Relative Risks) with confidence intervals from multiple studies on contraceptive use: NICHD Women's Contraceptive Study 2002, French E3N cohort Study 2005, Shanghai Women's Health Study 2009, Nurses' Health Study II 2010, Oxford Family Planning Association Study 2013, and Danish Sex Hormone Register Study 2017. The x-axis ranges from -1.5 to 2 with a vertical line at 1, indicating no effect reference.*
FDA Label Image

Structure (75083930 2ca4 48c9 A233 24783a0e50d4 02)

Structure (75083930 2ca4 48c9 A233 24783a0e50d4 02)
Chemical structure of Norgestimate and Ethinyl Estradiol, the active ingredients in the product Norgestimate and ethinyl estradiol by Lupin Pharmaceuticals, Inc. The image shows detailed molecular diagrams of both steroid compounds.*
FDA Label Image

Image (75083930 2ca4 48c9 A233 24783a0e50d4 03)

FDA Label Image

Fig1 (75083930 2ca4 48c9 A233 24783a0e50d4 04)

Fig1 (75083930 2ca4 48c9 A233 24783a0e50d4 04)
An illustration showing a vertical scale comparing pregnancy rates per 100 women per year from 'No birth control' at the bottom (85 or more pregnancies) to various contraceptive methods with fewer pregnancies toward the top. Methods include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*
FDA Label Image

Wallet Image (75083930 2ca4 48c9 A233 24783a0e50d4 05)

Wallet Image (75083930 2ca4 48c9 A233 24783a0e50d4 05)
An instruction diagram showing a weekly pill schedule for Norgestimate and ethinyl estradiol. It displays circles representing pill slots for each day of the week from Sunday to Saturday, organized into four weeks. The diagram includes arrows indicating the sequence to take pills and guidance to place a day label strip on the first day of the period if it does not start on Sunday. There is also a reminder for monthly self breast exams along the right side.*
FDA Label Image

Image (75083930 2ca4 48c9 A233 24783a0e50d4 06)

FDA Label Image

Carton (75083930 2ca4 48c9 A233 24783a0e50d4 07)

Carton (75083930 2ca4 48c9 A233 24783a0e50d4 07)
Packaging label for Norgestimate and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc., NDC 68180-838-73. The label shows strengths 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg in a multi-strength tablet pack of 3 blisters with 28 tablets each. Distributed by Lupin Pharmaceuticals, manufactured by Lupin Limited in India.*
FDA Label Image

Pouch (75083930 2ca4 48c9 A233 24783a0e50d4 08)

Pouch (75083930 2ca4 48c9 A233 24783a0e50d4 08)
Packaging label for Norgestimate and Ethinyl Estradiol Tablets USP by Lupin Pharmaceuticals, Inc., displaying multiple strengths: 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. The label indicates the product contains 1 blister pack of 28 tablets and is marked as Rx only. It includes usage and safety information, barcode, and manufacturer details.*
FDA Label Image

Blister (75083930 2ca4 48c9 A233 24783a0e50d4 09)

Blister (75083930 2ca4 48c9 A233 24783a0e50d4 09)
Blister pack labeling for Norgestimate and Ethinyl Estradiol Tablets USP, showing the lidding foil side and the forming foil/PVC side. The foil side displays product name with strengths 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg, storage instructions, manufacturer Lupin Limited, and distributor Lupin Pharmaceuticals, Inc. The PVC side has a calendar layout with days of the week and weeks numbered 2 through 4, indicating pill organization and sequence.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.